RALA Human shRNA Lentiviral Particle (Locus ID 5898)
CAT#: TL309957V
RALA - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.
Need custom lentivirus service?
Get a free quote
CNY 11,400.00
货期*
详询
规格
Cited in 2 publications. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | RALA Human shRNA Lentiviral Particle (Locus ID 5898) |
Locus ID | 5898 |
Synonyms | HINCONS; RAL |
Vector | pGFP-C-shLenti |
Format | Lentiviral particles |
RefSeq | NM_005402, NM_005402.1, NM_005402.2, NM_005402.3, BC039858, BC039858.1, BM930625, NM_005402.4 |
Summary | The product of this gene belongs to the small GTPase superfamily, Ras family of proteins. GTP-binding proteins mediate the transmembrane signaling initiated by the occupancy of certain cell surface receptors. This gene encodes a low molecular mass ras-like GTP-binding protein that shares about 50% similarity with other ras proteins. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer
,Thies, KA;Cole, MW;Schafer, RE;Spehar, JM;Richardson, DS;Steck, SA;Das, M;Lian, AW;Ray, A;Shakya, R;Knoblaugh, SE;Timmers, CD;Ostrowski, MC;Chakravarti, A;Sizemore, GM;Sizemore, ST;,
Breast cancer research : BCR
,PubMed ID 34118960
[RALA]
|
The Small G-Protein RalA Promotes Progression and Metastasis of Triple Negative Breast Cancer
,Thies, K;Cole, M;Schafer, R;Spehar, J;Richardson, D;Steck, S;Das, M;Lian, A;Ray, A;Shakya, R;Knoblaugh, S;Timmers, C;Ostrowski, M;Chakravarti, A;Sizemore, G;Sizemore, S;,
Research Square
[RALA]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...